Concord Medical Services Stock Book Value Per Share

CCM Stock

USD 0.58 0.08 16.00%

Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.

	Last Reported	Projected for Next Year
Book Value Per Share	(48.57)	(46.15)
Tangible Book Value Per Share	19.42	32.67

As of the 23rd of April 2024, Tangible Book Value Per Share is likely to grow to 32.67, though Book Value Per Share is likely to grow to (46.15).

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Concord Medical Services Company Book Value Per Share Analysis

Concord Medical's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Book Value per Share

Common Equity

Average Shares

More About Book Value Per Share | All Equity Analysis

Current Concord Medical Book Value Per Share

(48.87) X

Most of Concord Medical's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Concord Book Value Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Long Term Debt	Good Will	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.53	0.76	0.55	0.82	0.78	0.75	0.74	0.65	0.79	-0.7	0.44	0.21	-0.09	0.23	-0.31	-0.63	-0.75	0.3	0.32	-0.3	0.72	0.67	0.12	-0.75	-0.35	-0.19
Total Stockholder Equity	-0.53		-0.9	-0.69	-0.81	-0.59	-0.03	-0.92	-0.88	-0.84	0.95	-0.4	0.42	0.59	0.22	0.78	0.64	0.89	-0.27	-0.38	0.14	-0.92	-0.67	-0.05	0.9	0.71	0.6
Long Term Debt	0.76	-0.9		0.66	0.88	0.64	0.32	0.98	0.89	0.93	-0.94	0.4	-0.19	-0.5	-0.16	-0.66	-0.72	-0.94	0.41	0.33	-0.32	0.98	0.74	0.0	-0.9	-0.6	-0.46
Good Will	0.55	-0.69	0.66		0.69	0.35	0.31	0.75	0.81	0.76	-0.83	0.83	-0.34	-0.43	-0.03	-0.33	-0.21	-0.66	0.07	0.24	0.26	0.71	0.25	0.04	-0.73	-0.8	-0.71
Total Liab	0.82	-0.81	0.88	0.69		0.74	0.54	0.91	0.83	0.96	-0.9	0.53	-0.1	-0.19	0.26	-0.59	-0.76	-0.85	0.39	0.41	-0.27	0.9	0.81	0.04	-0.84	-0.69	-0.62
Intangible Assets	0.78	-0.59	0.64	0.35	0.74		0.47	0.63	0.48	0.61	-0.61	0.17	0.12	-0.07	0.2	-0.5	-0.85	-0.63	0.31	0.43	-0.3	0.61	0.85	0.29	-0.73	-0.22	-0.14
Common Stock	0.75	-0.03	0.32	0.31	0.54	0.47		0.34	0.25	0.46	-0.29	0.23	0.32	0.28	0.47	0.21	-0.38	-0.34	0.19	0.11	-0.27	0.33	0.42	0.02	-0.31	-0.22	-0.16
Property Plant Equipment	0.74	-0.92	0.98	0.75	0.91	0.63	0.34		0.91	0.95	-0.97	0.45	-0.33	-0.51	-0.14	-0.66	-0.7	-0.94	0.37	0.32	-0.24	1.0	0.73	0.02	-0.94	-0.73	-0.61
Current Deferred Revenue	0.65	-0.88	0.89	0.81	0.83	0.48	0.25	0.91		0.87	-0.94	0.59	-0.31	-0.41	-0.15	-0.59	-0.5	-0.86	0.2	0.42	-0.04	0.92	0.54	0.17	-0.86	-0.71	-0.65
Net Debt	0.79	-0.84	0.93	0.76	0.96	0.61	0.46	0.95	0.87		-0.93	0.59	-0.16	-0.37	0.14	-0.61	-0.67	-0.88	0.4	0.33	-0.22	0.94	0.72	-0.1	-0.83	-0.75	-0.6
Retained Earnings	-0.7	0.95	-0.94	-0.83	-0.9	-0.61	-0.29	-0.97	-0.94	-0.93		-0.55	0.33	0.51	0.11	0.64	0.62	0.92	-0.29	-0.38	0.11	-0.96	-0.66	-0.04	0.93	0.77	0.65
Accounts Payable	0.44	-0.4	0.4	0.83	0.53	0.17	0.23	0.45	0.59	0.59	-0.55		-0.03	-0.11	0.32	-0.19	0.03	-0.37	0.01	0.19	0.39	0.42	0.01	-0.06	-0.41	-0.6	-0.52
Net Receivables	0.21	0.42	-0.19	-0.34	-0.1	0.12	0.32	-0.33	-0.31	-0.16	0.33	-0.03		0.63	0.46	0.38	0.02	0.18	-0.12	0.12	-0.24	-0.32	-0.06	-0.03	0.31	0.58	0.61
Total Current Assets	-0.09	0.59	-0.5	-0.43	-0.19	-0.07	0.28	-0.51	-0.41	-0.37	0.51	-0.11	0.63		0.65	0.55	0.23	0.41	-0.11	-0.1	-0.21	-0.5	-0.19	0.25	0.49	0.41	0.22
Short Term Debt	0.23	0.22	-0.16	-0.03	0.26	0.2	0.47	-0.14	-0.15	0.14	0.11	0.32	0.46	0.65		0.12	-0.1	0.17	0.16	0.12	0.03	-0.14	0.17	-0.21	0.22	-0.1	-0.06
Short Term Investments	-0.31	0.78	-0.66	-0.33	-0.59	-0.5	0.21	-0.66	-0.59	-0.61	0.64	-0.19	0.38	0.55	0.12		0.66	0.57	-0.33	-0.5	0.03	-0.66	-0.65	0.05	0.61	0.42	0.34
Treasury Stock	-0.63	0.64	-0.72	-0.21	-0.76	-0.85	-0.38	-0.7	-0.5	-0.67	0.62	0.03	0.02	0.23	-0.1	0.66		0.64	-0.43	-0.48	0.39	-0.7	-0.98	-0.08	0.66	0.27	0.23
Net Tangible Assets	-0.75	0.89	-0.94	-0.66	-0.85	-0.63	-0.34	-0.94	-0.86	-0.88	0.92	-0.37	0.18	0.41	0.17	0.57	0.64		-0.2	-0.3	0.38	-0.94	-0.67	-0.05	0.95	0.62	0.48
Deferred Long Term Liab	0.3	-0.27	0.41	0.07	0.39	0.31	0.19	0.37	0.2	0.4	-0.29	0.01	-0.12	-0.11	0.16	-0.33	-0.43	-0.2		-0.17	-0.39	0.4	0.53	-0.19	-0.19	-0.24	-0.11
Long Term Investments	0.32	-0.38	0.33	0.24	0.41	0.43	0.11	0.32	0.42	0.33	-0.38	0.19	0.12	-0.1	0.12	-0.5	-0.48	-0.3	-0.17		0.3	0.32	0.43	0.01	-0.33	-0.14	-0.13
Short Long Term Debt	-0.3	0.14	-0.32	0.26	-0.27	-0.3	-0.27	-0.24	-0.04	-0.22	0.11	0.39	-0.24	-0.21	0.03	0.03	0.39	0.38	-0.39	0.3		-0.27	-0.41	-0.18	0.22	-0.15	-0.09
Long Term Debt Total	0.72	-0.92	0.98	0.71	0.9	0.61	0.33	1.0	0.92	0.94	-0.96	0.42	-0.32	-0.5	-0.14	-0.66	-0.7	-0.94	0.4	0.32	-0.27		0.74	0.02	-0.92	-0.72	-0.6
Capital Surpluse	0.67	-0.67	0.74	0.25	0.81	0.85	0.42	0.73	0.54	0.72	-0.66	0.01	-0.06	-0.19	0.17	-0.65	-0.98	-0.67	0.53	0.43	-0.41	0.74		0.05	-0.67	-0.37	-0.28
Cash And Equivalents	0.12	-0.05	0.0	0.04	0.04	0.29	0.02	0.02	0.17	-0.1	-0.04	-0.06	-0.03	0.25	-0.21	0.05	-0.08	-0.05	-0.19	0.01	-0.18	0.02	0.05		-0.19	0.26	-0.08
Net Invested Capital	-0.75	0.9	-0.9	-0.73	-0.84	-0.73	-0.31	-0.94	-0.86	-0.83	0.93	-0.41	0.31	0.49	0.22	0.61	0.66	0.95	-0.19	-0.33	0.22	-0.92	-0.67	-0.19		0.63	0.52
Net Working Capital	-0.35	0.71	-0.6	-0.8	-0.69	-0.22	-0.22	-0.73	-0.71	-0.75	0.77	-0.6	0.58	0.41	-0.1	0.42	0.27	0.62	-0.24	-0.14	-0.15	-0.72	-0.37	0.26	0.63		0.87
Capital Stock	-0.19	0.6	-0.46	-0.71	-0.62	-0.14	-0.16	-0.61	-0.65	-0.6	0.65	-0.52	0.61	0.22	-0.06	0.34	0.23	0.48	-0.11	-0.13	-0.09	-0.6	-0.28	-0.08	0.52	0.87

Click cells to compare fundamentals

The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

Competition

Predict Concord Medical

Book Value Per Share Over Time

Concord Common Stock Shares Outstanding

Common Stock Shares Outstanding

136.76 Million

At this time, Concord Medical's Common Stock Shares Outstanding is very stable compared to the past year.

In accordance with the recently published financial statements, the book value per share of Concord Medical Services is about -48.873 times. This is much higher than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The book value per share for all United States stocks is 102.53% higher than that of the company.

Concord Book Value Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.

Concord Medical is currently under evaluation in book value per share category among related companies.

Concord Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	806.0M	781.1M	556.7M	494.1M	341.0M	324.0M
Enterprise Value	2.6B	2.8B	3.1B	3.6B	3.5B	3.7B

Concord Fundamentals

	Return On Equity	-0.28
	Return On Asset	-0.048
	Profit Margin	(0.55) %
	Operating Margin	(0.98) %
	Current Valuation	7.17 B
	Shares Outstanding	43.42 M
	Shares Owned By Insiders	17.99 %
	Shares Owned By Institutions	0.10 %
	Number Of Shares Shorted	14.54 K
	Price To Earning	(3.90) X
	Price To Book	3.00 X
	Price To Sales	0.04 X
	Revenue	537.4 M
	Gross Profit	(152.41 M)
	EBITDA	(344.16 M)
	Net Income	(297.66 M)
	Cash And Equivalents	157.39 M
	Cash Per Share	1.72 X
	Total Debt	1.04 B
	Debt To Equity	1.25 %
	Current Ratio	0.71 X
	Book Value Per Share	(48.87) X
	Cash Flow From Operations	(276.47 M)
	Short Ratio	0.64 X
	Earnings Per Share	(0.96) X
	Target Price	1.2
	Number Of Employees	727
	Beta	-0.17
	Market Capitalization	21.72 M
	Total Asset	6.05 B
	Retained Earnings	(4.06 B)
	Working Capital	(1.33 B)
	Current Asset	1.51 B
	Current Liabilities	1.51 B
	Net Asset	6.05 B

About Concord Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Concord Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Concord Medical's short interest history, or implied volatility extrapolated from Concord Medical options trading.

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:

How To Invest In Concord

Details

Is Concord Stock a good investment?

Details

What is Concord Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis.

Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Concord Stock analysis

When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.

	Equity Valuation Check real value of public entities based on technical and fundamental data
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences

Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.96)

Revenue Per Share

12.302

Quarterly Revenue Growth

(0.23)

Return On Assets

(0.05)

Return On Equity

(0.28)

The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Concord Medical Services Stock Book Value Per Share

Concord Medical Services Company Book Value Per Share Analysis

Book Value per Share

Common Equity

Average Shares

Current Concord Medical Book Value Per Share

Concord Book Value Per Share Driver Correlations

Concord Common Stock Shares Outstanding

Common Stock Shares Outstanding

136.76 Million

Concord Book Value Per Share Peer Comparison

Concord Medical Current Valuation Drivers

Concord Fundamentals

About Concord Medical Fundamental Analysis

Complementary Tools for Concord Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY